Epsilon-amanitin: Difference between revisions

Jump to navigation Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
Line 41: Line 41:


==References==
==References==
{{reflist}}
{{reflist|2}}


==See also==
==See also==

Latest revision as of 17:10, 4 September 2012

WikiDoc Resources for Epsilon-amanitin

Articles

Most recent articles on Epsilon-amanitin

Most cited articles on Epsilon-amanitin

Review articles on Epsilon-amanitin

Articles on Epsilon-amanitin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Epsilon-amanitin

Images of Epsilon-amanitin

Photos of Epsilon-amanitin

Podcasts & MP3s on Epsilon-amanitin

Videos on Epsilon-amanitin

Evidence Based Medicine

Cochrane Collaboration on Epsilon-amanitin

Bandolier on Epsilon-amanitin

TRIP on Epsilon-amanitin

Clinical Trials

Ongoing Trials on Epsilon-amanitin at Clinical Trials.gov

Trial results on Epsilon-amanitin

Clinical Trials on Epsilon-amanitin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Epsilon-amanitin

NICE Guidance on Epsilon-amanitin

NHS PRODIGY Guidance

FDA on Epsilon-amanitin

CDC on Epsilon-amanitin

Books

Books on Epsilon-amanitin

News

Epsilon-amanitin in the news

Be alerted to news on Epsilon-amanitin

News trends on Epsilon-amanitin

Commentary

Blogs on Epsilon-amanitin

Definitions

Definitions of Epsilon-amanitin

Patient Resources / Community

Patient resources on Epsilon-amanitin

Discussion groups on Epsilon-amanitin

Patient Handouts on Epsilon-amanitin

Directions to Hospitals Treating Epsilon-amanitin

Risk calculators and risk factors for Epsilon-amanitin

Healthcare Provider Resources

Symptoms of Epsilon-amanitin

Causes & Risk Factors for Epsilon-amanitin

Diagnostic studies for Epsilon-amanitin

Treatment of Epsilon-amanitin

Continuing Medical Education (CME)

CME Programs on Epsilon-amanitin

International

Epsilon-amanitin en Espanol

Epsilon-amanitin en Francais

Business

Epsilon-amanitin in the Marketplace

Patents on Epsilon-amanitin

Experimental / Informatics

List of terms related to Epsilon-amanitin


Template:Chembox E numberTemplate:Chembox AppearanceTemplate:Chembox SolubilityInWaterTemplate:Chembox Solubility
ε-Amanitin
File:Epsilon-amanitin structure.png
File:Epsilon amanitine 3d structure.png
Names
Other names
Amanine
Identifiers
3D model (JSmol)
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
Properties
C39H53N9O14S
Molar mass 903.96 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

epsilon-Amanitin or ε-amanitin is a cyclic peptide. It is an amatoxin, all of which are found in several members of the Amanita genus of mushrooms. The oral of ε-Amanitin is approximately 0.1 mg/kg.

Toxicology

Like other amatoxins, ε-amanitin an inhibitor of RNA polymerase II. Upon ingestion, it binds to the RNA polymerase II enzyme which completely prevents mRNA synthesis, effectively causing cytolysis of hepatocytes (liver cells) and kidney cells.[1]

References

  1. M. Cochet-Meillhac and Chambon P. (1974). Biochim Biophys Acta. 353: 160–184 http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZI8h7t:1. Missing or empty |title= (help)

See also

External links


Template:WH Template:WS